NCT01937338View on ClinicalTrials.gov

Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
LPS Challenge, Neutrophils
Interventions
DRUG

AZD7624

nebuliser solution; 20 mg/mL for inhalation

DRUG

Placebo

nebuliser solution for inhalation

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY